TrialClinical rheumatology2013

A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII:Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis.

Xiao-Xiang Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.